High Cbd Chemotypes

High-CBD chemotypes represent cannabis genetics selected for elevated cannabidiol (CBD) production relative to THC, typically showing CBD:THC ratios of 1:1 or greater, sometimes approaching CBD-dominant profiles. These chemotypes emerged from selective breeding programs beginning in the early 2000s, with breeders stabilizing traits found in specific landrace populations and modern crosses. High-CBD strains are distinguished by their cannabinoid profile rather than terpene dominance, making them valuable for breeding programs targeting diverse end-use categories. Lineage records frequently report that high-CBD chemotypes derive from hemp-adjacent genetics, European breeding lines, or deliberate crosses selecting for low-THC expression. Understanding CBD chemotypes is essential for breeders developing balanced cannabinoid portfolios and for preserving genetic diversity in cannabis breeding

Breeders use high-CBD chemotypes as donor parents to introduce CBD-dominant or balanced traits into new cultivars, often crossing them with aromatic or structurally desirable genetics. Stabilizing these chemotypes through selective breeding requires multiple generations to ensure consistent CBD expression across offspring and environmental conditions.